Michael Chambers · President and CEO, Aldevron
Michael Chambers has served as President and CEO of Aldevron since founding the company in 1998 as an undergraduate at North Dakota State University (NDSU) in Fargo. He and fellow student John Ballantyne started producing plasmid DNA in a small lab at NDSU for use by researchers in the biotech community.
Over the next 20 years, they expanded and grew the business in Fargo, North Dakota, to become one of the industry’s leading — and most respected — contract manufacturing organizations. Aldevron products and services are key components of the world’s most innovative gene and cell therapy commercial products.
This year, Michael was named one of the “100 Most Intriguing Entrepreneurs” by Goldman Sachs and honored at its “2018 Builders and Innovators Summit” in October.
Under his vision and leadership, Aldevron acquired Genovac Antibody Technology of Freiburg, Germany, in 2004. Five years later, the company expanded into protein production in Madison, Wisconsin. Recently, the company completed construction of a 70,000 square-foot building in Fargo, the largest plasmid DNA manufacturing facility in the world. Michael continues to lead the Aldevron team of more than 200 on the next phase of its growth trajectory.
Michael received Bachelor of Science degrees in biotechnology, chemistry and microbiology from North Dakota State University.Back to Schedule